Cefepime LDP-Laboratorios Torlan 2000 mg inj./inf. sol. (pwdr.) i.v./i.m. vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Cefepime Dihydrochloride Monohydrate 2378,28 mg - Eq. Cefepime 2000 mg

Available from:

LDP Laboratorios Torlan S.A.

ATC code:

J01DE01

INN (International Name):

Cefepime Dihydrochloride Monohydrate

Dosage:

2000 mg

Pharmaceutical form:

Powder for solution for injection/infusion

Composition:

Cefepime Dihydrochloride Monohydrate 2378.28 mg

Administration route:

Intramuscular use; Intravenous use

Therapeutic area:

Cefepime

Product summary:

CTI code: 537440-06 - Pack size: 50 x 2000 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537440-07 - Pack size: 100 x 2000 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537440-02 - Pack size: 5 x 2000 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537440-03 - Pack size: 10 x 2000 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537440-04 - Pack size: 20 x 2000 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537440-05 - Pack size: 25 x 2000 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537440-01 - Pack size: 2000 mg - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2018-12-17